OmniAbpublic
OmniAb, Inc. operates as a biotech company. The Company develops therapeutic antibody discovery platform that provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics. OmniAb serves biopharmaceutical companies and research institutions worldwide.
Funding
Every round, secondary, debt facility or acquisition involving OmniAb that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in